As death rates from substance use disorders escalate, clinicians seek knowledge and awareness of opioid stewardship practices: approaches to opioid alternatives and judicious use of opioids in the treatment of painful conditions. Additional focus will be on prevention of substance use disorders and identification and treatment of substance use disorders with evidence based medications. Participants will understand the impact of the evolving drug supply in supporting patients with substance use ...

Content Last Review Date: September 3, 2024Pennsylvania Substance Use Navigation Program Educational Modules for Implementing MOUD in Emergency Departments 1. Driving the Cultural Shift: Reducing Stigma in the Emergency Department (ED) Topics covered: a) EDs are an entry point to treatment b) Addiction is a treatable chronic condition c) Changing the thought process around MOUD in the ED and eliminating biases that may affect quality of care d) Review screening opportunities 2. Harm Reduction...

At Penn Medicine, our program has grown in response to the devastating impact of opioid use in our vulnerable community. Yet, based on electronic medical record data, fewer than 20% of patients receive MOUDs while admitted to the hospital, and there are treatment needs in our community that are not addressed by our outpatient clinics. Now is the time to expand provider readiness and equity in treating OUD by preparing our clinical staff at Penn Medicine to provide comprehensive addiction care wi...

As death rates from opioids continue to climb one of the more important tools to manage opioid use disorder (OUD) is proper opioid stewardship.  The presenter will discuss the effect of OUD and how prescribers opioids can affect a change.

For a list of Penn Medicine DEA-Required Opioid Training activities, click here.Q. Why do we have to complete this trainingA. On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.  Below is information on this new requirement.Q. When does the new...

Last Reviewed Date: March 4, 2024THERE IS NO FEE TO REGISTER FOR THIS ACTIVITY, HOWEVER REGISTRATION IS REQUIRED.IF YOU HAVE ALREADY RECEIVED CREDIT FOR THIS ACTIVITY, CREDIT CAN NOT BE RE-ISSUED. The Pennsylvania Prescription Drug Monitoring Program (PDMP) and faculty experts from Penn Medicine are offering an education curriculum for prescribers on best practices for using the PDMP and on how to address substance use disorder with patients. We invite you to view these ...

The re-emergence of fentanyl has created a heightened need for clinicians to employ medications designed to treat opioid use disorder (MOUD) and implement harm reduction strategies.